Now out NatureRevClinOncol

📚In The Lancet we join with people w serious illness, IAHPC, WHPCA, ICPCN, Palliative Care in Humanitarian Aid Situations, APCA, EAPC VZW, ALCP, Cicely Saunders Institute at King's, ELNEC, Pallium India & many more to put forth a global vision for #PalliativeCare in the next decade. thelancet.com/journals/lance… OncoAlert

THREAD: Young Adults & Upper GI Cancer—Why Women Are at Increasing Risk New study in AJG - The American Journal of Gastroenterology (April 2025) reveals rising rates of upper GI cancers in people under 55—especially young women. Read full article bit.ly/3ECc5J8 1/ UGI cancers include the esophagus,

It’s been a remarkable year marked by dedication, discovery, and impact. Congratulations to Malak on her outstanding presentations at #DDW2025. Grateful for the hard work of our entire team—many unsung heroes whose contributions made this possible. Proud 2 be part of this journey

1/4🧵 In patients undergoing cardiac stress testing w/ PET, does rest flow matter❓ In an analysis of >8k patients, we find that it does, esp. in patients with a preserved EF. Link📜: doi.org/10.1093/ehjci/… Mouaz Al-Mallah, M.D MSc Maria Alwan ASNC Society Houston Methodist EHJCVI Editor-in-Chief

Over the past 41 years, death due to ischemic heart disease did not decline in countries with low socioeconomic development, research shows Ahmed Sayed Houston Methodist Salim Virani Erin D. Michos, M.D. @annmarienavar LaPrincess C. Brewer, MD, MPH ahajrnls.org/3EWOnYl

Nearly half of the patients referred for CAR-T therapy at an academic center did not receive it, with contributing factors including rapid disease progression, lack of suitable therapies, racial disparities, and logistical challenges. ja.ma/3YHU2Is Roni Shouval

The past decade has witnessed remarkable advances in deciphering the pathophysiology of acute lymphoblastic leukemia (ALL) and in developing novel targeted therapies. Revisit this comprehensive review by Hagop Kantarjian,MD et al: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #LeuSM

Neoadjuvant PD-1/PD-L1 blockade combined with chemotherapy improved pathological response rates and surgical resectability in patients with T4 and/or N2-N3 stage III NSCLC. ja.ma/43beXGr

🔥hot off the press: Redefining cancer care: the case for an onco-gastroenterology subspecialty Nature Reviews Gastroenterology & Hepatology bit.ly/3FnDxdV 👉Multidisciplinary team work is key 👉Onco-gastroenterology as a distinct subspecialty ESMO - Eur. Oncology EASL Education ILCA

According to many recent reports, colon cancer is increasing in the young. However, most of the increase can now be attributed to the reclassification of appendix NET/carcinoids. Recommendations for colon cancer screening at an earlier age may be affected. oxford.ly/3HCOAkc

NEW content online! Neuro-immune cross-talk in cancer bit.ly/3TuULJG

Immune checkpoint inhibitors can improve survival in solid organ transplant recipients with advanced cancers, but survival rates remain limited. #TSANZConf TSANZ ja.ma/43Rsa7C

From JAMA: Early-onset gastrointestinal cancers are among the largest subset of early-onset cancers globally. This JAMA Review summarizes current evidence on early-onset gastrointestinal cancers. ja.ma/3GSXvOo Kimmie Ng, MD, MPH Dana-Farber

A risk-reducing mastectomy is cost-effective for women aged 30 to 55 with a lifetime breast cancer risk of 35% or higher, regardless of carrying BRCA1, BRCA2, or PALB2 variants. ja.ma/46qoFXo

Do heart transplant patients always need invasive angio to screen for graft vasculopathy❓ 📜authors.elsevier.com/a/1lWfA,i2Xs0R… In this meta-analysis, CTA/PET had pretty respectable sensitivity/NPV for ruling out graft vasculopathy compared to a gold standard of invasive angiography.

Nearly half of patients referred for CAR-T therapy at an academic center did not receive it, influenced by factors like rapid disease progression, lack of appropriate therapies, racial disparities, and logistical challenges. ja.ma/3TWGJ44 Roni Shouval

"Caring for fasting oncology patients during Ramadan requires a thoughtful, individualized approach." This Viewpoint discusses how oncology clinicians can provide culturally sensitive care for Muslim cancer patients fasting during Ramadan. ja.ma/464Hiyb

Four-year NATALEE trial results show ribociclib plus NSAI maintains invasive disease-free survival benefit over NSAI alone in hormone receptor–positive/ERBB2-negative early breast cancer. ja.ma/4nNqEdE